Method for calibrating a device for measuring the concentration of creatinine
US-11874285-B2 · Jan 16, 2024 · US
US12529673B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12529673-B2 |
| Application number | US-201916429886-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 3, 2019 |
| Priority date | Apr 5, 2019 |
| Publication date | Jan 20, 2026 |
| Grant date | Jan 20, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Techniques includes measuring, using a creatine sensor, a creatine sensor current signal (ΔI2) of a first calibration solution (CS2). A creatine sensor sensitivity (Slope) for the creatine sensor is based on the creatine sensor current signal (ΔI2). The first calibration solution (CS2) has a known concentration of creatine (CR_CS2), a known concentration of creatinine (CREA_CS2), and a stable ratio of creatine to creatinine over a range of temperatures for a predefined shelf-life of the first calibration solution (CS2). The Techniques include measuring, using the creatine sensor, a measured creatine concentration (MCR_CS3) of a second calibration solution (CS3). The second calibration solution (CS3) has an initial known creatine concentration (CR_CS3), an initial known creatinine concentration (CREA_CS3), and an unstable ratio of creatine to creatinine that changes over the predefined shelf-life. Concentrations of creatine and creatinine in a sample are thereafter estimated.
Opening claim text (preview).
We claim: 1 . A method comprising: measuring, using a creatine sensor, a creatine sensor current signal (ΔI2) of a first calibration solution (CS2), where a creatine sensor sensitivity (Slope) for the creatine sensor is based on the creatine sensor current signal (ΔI2), where the first calibration solution (CS2) has a known concentration of creatine (CR_CS2), a known concentration of creatinine (CREA_CS2), and a stable ratio of creatine to creatinine over a range of temperatures for a predefined shelf-life of the first calibration solution (CS2), and where the creatine sensor comprises a diffusion membrane over an enzyme layer and is configured to generate the creatine sensor current signal (ΔI2) based on creatine entering the enzyme through the diffusion membrane; measuring, using the creatine sensor, a creatine concentration (MCR_CS3) of a second calibration solution (CS3), where the second calibration solution (CS3) has an initial known creatine concentration (CR_CS3), an initial known creatinine concentration (CREA_CS3), and an unstable ratio of creatine to creatinine that changes over the predefined shelf-life; comparing, using equal molar conversion, MCR_CS3 of CS3 to CR_CS3 to obtain a creatine concentration correction factor that corresponds to a difference between the MCR_CS3 and CR_CS3 caused by decay of the creatine concentration over time; measuring, using a creatinine sensor: a creatinine sensor current signal (ΔI2′) of CS2 and a creatinine sensor current signal (ΔI3′) of CS3, where the creatinine sensor comprises a diffusion membrane over an enzyme layer and is configured to generate the creatinine sensor current signal (ΔI2′) based on creatinine entering the enzyme through the diffusion membrane; obtaining a creatinine concentration of CS3 (MCREA_CS3); determining a first creatinine sensor sensitivity (Slope1) based on at least some of the measurements obtained by the measuring performed using the creatinine sensor; determining a second creatinine sensor sensitivity (Slope2) based on at least some of the measurements obtained by the measuring performed using the creatinine sensor; adjusting Slope1 and Slope2 for the creatinine sensor based on the creatine concentration correction factor; estimating a creatinine concentration in a sample based on a sensor current signal of the sample from the creatinine sensor, the Slope1 as adjusted, and the Slope2 as adjusted; and estimating a creatine concentration in the sample based on a sensor current signal of the sample from the creatine sensor and the Slope. 2 . The method of claim 1 , wherein the Slope=ΔI2/CR_CS2. 3 . The method of claim 1 , wherein the Slope1=(MCR_CS3*ΔI2′−CR_CS2*ΔI3′)/(CREA_CS2*MCR_CS3−MCREA_CS3*CR_CS2. 4 . The method of claim 1 , wherein the Slope2=(CREA_CS2*ΔI3′−MCREA_CS3*ΔI2′)/(CREA_CS2*MCR_CS3-MCREA_CS3*CR CS2). 5 . The method of claim 1 , wherein the stable ratio of creatine to creatinine in the CS2 is 1.5 to 2. 6 . The method of claim 1 , wherein the CS2 includes about 2-5 mg/dL (milligrams per deciliter) of creatine and about 1-3 mg/dL of creatinine. 7 . The method of claim 6 , wherein the stable ratio of creatine to creatinine in the CS2 is 1.5 to 2. 8 . The method of claim 7 , wherein the stable ratio of creatine to creatinine in the CS2 is stable for a minimum of 8 months. 9 . The method of claim 1 , wherein the CS3 includes between 2 and 8 mg/dL (milligrams per deciliter) of creatine and between 0 and 1 mg/dL of creatinine. 10 . The method of claim 9 , wherein the unstable ratio of creatine to creatinine in (milligrams per deciliter) CS3 is 4 to 70. 11 . The method of claim 1 , further comprising: adjusting the estimate of the creatine concentration in the sample using the creatine concentration correction factor. 12 . The method of claim 1 , wherein the CS2 is different from the CS3. 13 . A method, comprising: measuring, using a creatine sensor, a creatine sensor current signal (ΔI2) of a first calibration solution (CS2), where a creatine sensor sensitivity (Slope) for the creatine sensor being is based on the creatine sensor current signal (ΔI2), where the first calibration solution (CS2) has a known concentration of creatine (CR_CS2), a known concentration of creatinine (CREA_CS2), and a stable ratio of creatine to creatinine over a range of temperatures for a predefined shelf-life of the first calibration solution (CS2), and where the creatine sensor comprises a diffusion membrane over an enzyme layer and is configured to generate the creatine sensor current signal (ΔI2) based on creatine entering the enzyme through the diffusion membrane; measuring, using a creatinine sensor, a creatinine sensor current signal (ΔI2′) of the first calibration solution (CS2) and a creatinine sensor current signal (ΔI3′) of a second calibration solution (CS3), where the second calibration solution (CS3) has an initial known creatine concentration (CR_CS3), an initial known creatinine concentration (CREA_CS3), and an unstable ratio of creatine to creatinine that changes over the predefined shelf-life, wherein and where the creatinine sensor comprises a diffusion membrane over an enzyme layer and is configured to generate the creatinine sensor current signal (ΔI2′) based on creatinine entering the enzyme through the diffusion membrane; determining a first creatinine sensor sensitivity (Slope1) based on at least some of measurements obtained by the measuring performed using the creatinine sensor; determining a second creatinine sensor sensitivity (Slope2) based on at least some of the measurements obtained by the measuring performed using the creatinine sensor; measuring, using the creatine sensor, a creatine concentration of a first correction solution (COR1) having a known creatine concentration (CR_COR1), a known creatinine concentration (CREA_COR1), and a stable ratio of creatine to creatinine; measuring, using the creatinine sensor, a creatinine concentration of the first correction solution (COR1); comparing, using equal molar conversion, the creatine concentration measured by the creatine sensor to the known creatine concentration (CR_COR1) of the first correction solution and comparing, using equal molar conversion, the creatinine concentration measured by the creatinine sensor to the known creatinine concentration (CREA_COR1) of the first correction solution to determine, respectively, a creatine concentration correction factor and a creatinine concentration correction factor; adjusting Slope1 and Slope2 for the creatinine sensor based on the creatine concentration correction factor; and estimating a creatinine concentration in a sample based on values of the Slope, the Slope1 as adjusted, the Slope2 as adjusted, the creatine concentration correction factor, the creatinine concentration correction factor, the creatine sensor current signal (ΔI2), and the creatinine sensor current signal (ΔI2′). 14 . The method of claim 13 , wherein the COR1 comprises a concentration of creatine between 0 and 2 mg/dL and a concentration of creatinine between 1 and 3 mg/dL (milligrams per deciliter). 15 . The method of claim 13 , further comprising: measuring, using the creatine sensor, a creatine concentration of a second correction solution (COR2) having a known creatine concentration (CR_COR2) and a known creatinine concentration (CREA_COR2), wherein the second correction solution (COR2) has a stable ratio of creatine to creatinine; and measuring, using the creatinine sensor, a creatinine concentration (CREA_COR2) of the COR2. 16 . The method of claim 15 , wherein the Slope1=(CR_C
Electrode membranes · CPC title
involving creatine or creatinine · CPC title
involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence) · CPC title
Composite membranes; Ultra-thin membranes · CPC title
for evaluating statistical data {, e.g. average values, frequency distributions, probability functions, regression analysis (forecasting specially adapted for a specific administrative, business or logistic context G06Q10/04)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.